Mon Sep 23 17:42:55 UTC 2024: ## StockNews.com and Other Analysts Issue Ratings for Over 80 Companies
**New York, NY** – September 23, 2024 – A flurry of analysts’ ratings for various companies hit the market today. StockNews.com, Royal Bank of Canada, Wells Fargo, Canaccord Genuity, Needham & Company, Guggenheim, Morgan Stanley, BMO Capital Markets, Deutsche Bank, Craig Hallum, and Moffett Nathanson all issued new coverage and ratings on a total of over 80 stocks.
StockNews.com, in particular, was busy, issuing ratings for over 50 companies, including a “Strong Buy” for ARC Document Solutions and Educational Development, and a “Buy” for Mannatech and Natural Alternatives International. However, StockNews.com also issued numerous “Sell” ratings, including for ATA Creativity Global, Ayala Pharmaceuticals, Akari Therapeutics, China Green Agriculture, ClearSign Technologies, and Euro Tech.
Other analysts also weighed in with their own ratings. Royal Bank of Canada initiated coverage on CG Oncology with an “Outperform” rating and a $66.00 price target. Wells Fargo & Company gave Core & Main an “Overweight” rating and a $52.00 target price. Canaccord Genuity Group Inc. rated Core Scientific a “Buy” with a $16.00 target price. Needham & Company LLC gave CrowdStrike a “Buy” rating and a $360.00 price target. Guggenheim rated Keros Therapeutics a “Buy” with a $96.00 price target. Morgan Stanley gave Structure Therapeutics an “Overweight” rating and a $118.00 target price. BMO Capital Markets rated Onestream “Outperform” with a $38.00 target price. Deutsche Bank Aktiengesellschaft gave Pinterest a “Buy” rating and a $43.00 target price. Finally, Craig Hallum issued a “Buy” rating and a $13.00 price target for Westrock Coffee.
With such a diverse range of ratings, investors will need to carefully consider the specific factors behind each recommendation before making any investment decisions.
First Piper 